Curis Lifesciences IPO listing price is [●], issue price is [●], and currently trading at [●] as on [●]. Curis Lifesciences IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Curis Lifesciences IPO is a Book Building listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Swastika Investmart is the merchant banker of Curis Lifesciences IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st December 2024.
Curis Lifesciences IPO offer price is [●] and got listed at [●]. Read Curis Lifesciences IPO details mentioned above.The IPO of Curis Lifesciences Limited was listed on [●]. As of today, Curis Lifesciences IPO is trading at [●], compared to the previous day’s close of [●]. Read the report above for detailed IPO performance.
The issue price of Curis Lifesciences IPO was [●] per equity share.
Curis Lifesciences IPO was listed at ₹ on the stock exchange on [●]. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of [●], the current market price of Curis Lifesciences IPO is [●].
The 52-week high for Curis Lifesciences IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Curis Lifesciences IPO listed at [●] against the issue price of [●] per equity share, showing a listing day gain/loss of -1 (-100.00%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Curis Lifesciences IPO stock moved from its listing price of [●] to the current price of ₹[●] per equity share, reflecting a change of 0.00% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Curis Lifesciences IPO issue date of [●] and CMP of ₹[●], the estimated CAGR is approximately 0%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Curis Lifesciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Curis Lifesciences Financial Review Page
Merchant Banker(s) of Curis Lifesciences IPO: Swastika Investmart Limited
Curis Lifesciences IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Curis Lifesciences IPO listed at a listing price of against the offer price of .
The current market price of Curis Lifesciences is .
Why Us?